Cereblue Limited - Net Worth and Insider Trading
Cereblue Limited Net Worth
The estimated net worth of Cereblue Limited is at least $364 Million dollars as of 2024-10-06. Cereblue Limited is the 2201 Interest of corporation controlled by you of Lepu Biopharma Co Ltd and owns about 90,000,000 shares of Lepu Biopharma Co Ltd (HKSE:02157) stock worth over $364 Million. Details can be seen in Cereblue Limited's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Cereblue Limited has not made any transactions after 2022-02-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Cereblue Limited
Cereblue Limited Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Cereblue Limited owns 1 companies in total, including Lepu Biopharma Co Ltd (HKSE:02157) .
Click here to see the complete history of Cereblue Limited’s form 4 insider trades.
Insider Ownership Summary of Cereblue Limited
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:02157 | Lepu Biopharma Co Ltd | 2022-02-23 | 2201 Interest of corporation controlled by you |
Cereblue Limited Latest Holdings Summary
Cereblue Limited currently owns a total of 1 stock. Cereblue Limited owns 90,000,000 shares of Lepu Biopharma Co Ltd (HKSE:02157) as of February 23, 2022, with a value of $364 Million.
Latest Holdings of Cereblue Limited
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:02157 | Lepu Biopharma Co Ltd | 2022-02-23 | 90,000,000 | 4.04 | 363,600,000 |
Holding Weightings of Cereblue Limited
Cereblue Limited Form 4 Trading Tracker
According to the SEC Form 4 filings, Cereblue Limited has made a total of 1 transactions in Lepu Biopharma Co Ltd (HKSE:02157) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Lepu Biopharma Co Ltd is the sale of 90,000,000 shares on February 23, 2022, which brought Cereblue Limited around $0.
Insider Trading History of Cereblue Limited
- 1
Cereblue Limited Trading Performance
Cereblue Limited Ownership Network
Cereblue Limited Owned Company Details
What does Lepu Biopharma Co Ltd do?
Who are the key executives at Lepu Biopharma Co Ltd?
Cereblue Limited is the 2201 Interest of corporation controlled by you of Lepu Biopharma Co Ltd. Other key executives at Lepu Biopharma Co Ltd include 2201 Interest of corporation controlled by you Pu Zhongjie , 2201 Interest of corporation controlled by you Hu Chaohong , and 2201 Interest of corporation controlled by you Pu Jue .
Lepu Biopharma Co Ltd (HKSE:02157) Insider Trades Summary
Over the past 18 months, Cereblue Limited made no insider transaction in Lepu Biopharma Co Ltd (HKSE:02157). Other recent insider transactions involving Lepu Biopharma Co Ltd (HKSE:02157) include a net sale of 1,683,000 shares made by Hu Chaohong , a net sale of 3,910,000 shares made by Su Rongyu , and a net sale of 3,910,000 shares made by Hao Chunmei .
In summary, during the past 3 months, insiders sold 0 shares of Lepu Biopharma Co Ltd (HKSE:02157) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 10,089,000 shares of Lepu Biopharma Co Ltd (HKSE:02157) were sold and 0 shares were bought by its insiders, resulting in a net sale of 10,089,000 shares.
Lepu Biopharma Co Ltd (HKSE:02157)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lepu Biopharma Co Ltd Insider Transactions
Cereblue Limited Mailing Address
Above is the net worth, insider trading, and ownership report for Cereblue Limited. Currently GuruFocus does not have mailing address information for Cereblue Limited.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
